On August 9, 2019, the bio-pharmaceutical innovation service alliance of chongqing liangjiang new district was officially launched, with chongqing zhongguancun lianchuang medical engineering transformation center as the director unit, and 21 units such as chongqing Kerun biology and yaoyou pharmaceutical co., ltd. as the deputy director units.

    The alliance will work through the government guidance and social future, efficient integration of two rivers and biological medicine industry chain upstream and downstream enterprises, research institutes, universities, medical institutions, investment and financing institutions and other industries and innovation resources, perfect and improve the government, industry, hospital, university, scientific research, capital of innovation mechanism, set up the pharmaceutical industry collaboration, research and development innovation service, ZhengYinQi three platforms of research collaboration for pharmaceutical companies to provide professional analysis testing, GLP, GMP and GCP, hatch results transformation, investment and financing services, improve liangjiang new area of biological medicine industry development level, Promoting the development of the bio-pharmaceutical industry in liangjiang new area into the fast track and jointly building a bio-pharmaceutical market of 100 billion yuan in chongqing.